IRESSA

NDC 0310-0482 · AstraZeneca Pharmaceuticals LP

Generic nameGefitinib

Dosage formTABLET, COATED

RouteORAL

Active ingredient(s)GEFITINIB

Strength250 mg/1

Pharmacologic classKinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]

Marketing categoryNDA

Packages

0310-0482-30 — 30 TABLET, COATED in 1 BOTTLE (0310-0482-30)

FDA lists these products with the same active ingredient.

0480-4053 — Gefitinib, 50742-366 — Gefitinib, 67184-0531 — Gefitinib, 69339-168 — Gefitinib

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.